Publication | Closed Access

A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow

Immature CellsHematological MalignancyAutoimmune DiseaseMixed-phenotype Acute LeukemiaMalignant Blood DisorderNormal Bone MarrowHematologyImmunologyAutoimmunityCgl Blast CrisesAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyMyeloid Neoplasia